Eric Ciamporcero Selected Research

Eric Ciamporcero Research Topics

Disease

15	Neoplasms (Cancer) 05/2022 - 01/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 01/2011
3	Melanoma (Melanoma, Malignant) 12/2015 - 12/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 11/2016
2	Colonic Neoplasms (Colon Cancer) 01/2012 - 01/2012
1	Triple Negative Breast Neoplasms 03/2021
1	Hypoxia (Hypoxemia) 01/2016
1	Disease Progression 02/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Cardiomyopathies (Cardiomyopathy) 10/2011
1	Atherosclerotic Plaque (Atheroma) 10/2011
1	Neointima 10/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011
1	Inflammation (Inflammations) 10/2011
1	Atherosclerosis 10/2011
1	Hemorrhage 10/2011

Drug/Important Bio-Agent (IBA)

4	Sunitinib (Sutent)FDA Link 12/2017 - 01/2014
4	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2015 - 01/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2013
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 11/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 12/2017
2	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2014
2	LigandsIBA 01/2014 - 01/2012
2	CyclodextrinsIBA 12/2013 - 11/2012
2	1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA 01/2012 - 01/2012
1	olaparibIBA 05/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2022
1	cisplatin-DNA adductIBA 03/2021
1	AngiopoietinsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	trebananibIBA 01/2020
1	AntioxidantsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Histones (Histone)IBA 12/2017
1	TransferasesIBA 12/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	ChromatinIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2016
1	NanocapsulesIBA 12/2015
1	SuperantigensIBA 02/2015
1	Cancer VaccinesIBA 02/2015
1	tasquinimodIBA 02/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2015
1	CrizotinibIBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2015
1	Axitinib (AG 013736)IBA 01/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015
1	afliberceptIBA 01/2014
1	AldehydesIBA 12/2013
1	Dietary ProteinsIBA 12/2013
1	Plant ProteinsIBA 12/2013
1	Histone MethyltransferasesIBA 12/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2013
1	A 7 (A-7)IBA 12/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2013
1	AndrogensIBA 11/2012
1	CamptothecinIBA 11/2012
1	Topoisomerase I InhibitorsIBA 11/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2012
1	Clofibrate FDA Link 01/2012
1	Rosiglitazone (Avandia)FDA Link 01/2012
1	ciprofibrateIBA 01/2012
1	Fibric Acids (Fibrates)IBA 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2011
1	Thromboplastin (Tissue Factor)IBA 10/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	PanobinostatIBA 01/2011

Therapy/Procedure

5	Therapeutics 01/2020 - 10/2011
1	Nephrectomy 01/2016
1	Topical Administration 12/2015
1	Castration 02/2015
1	Immunotherapy 02/2015
1	Heart Transplantation (Grafting, Heart) 10/2011